Blueprint Medicines (BPMC) Prices 4.71M Share Common Offering at $69/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Pre-Open Stock Movers 01/22: (AKCA) (ACMR) (SPCE) Higher; (FCEL) (NVAX) (BPMC) Lower (more...)
January 22, 2020 9:28 AM ESTToday's Per-Open Stock Movers:
FuelCell Energy (NASDAQ: FCEL) 26% LOWER; reported Q4 EPS of ($0.23), $0.12 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $11 million versus the consensus estimate of $11.51 million.
Novavax (NASDAQ: NVAX) 15.2% LOWER; files prospectus supplement relates to the issuance and sale of up to $100,000,000 of our common stock from time to time through or to our sales agent, B. Riley FBR, Inc., or BRFBR
Akcea Therapeutics, Inc. (NASDAQ:... More
After-Hours Stock Movers 01/21: (NAVI) (CIT) (IBM) Higher; (NVAX) (BPMC) (ADAP) Lower (more...)
January 21, 2020 5:41 PM ESTToday's After-Hours Stock Movers:
Novavax (NASDAQ: NVAX) 15.2% LOWER; files prospectus supplement relates to the issuance and sale of up to $100,000,000 of our common stock from time to time through or to our sales agent, B. Riley FBR, Inc., or BRFBR
Navient (NASDAQ: NAVI) 6.2% HIGHER; reported Q4 EPS of $0.67, $0.10 better than the analyst estimate of $0.57.
CIT Group Inc. (NYSE: CIT) 5.8% HIGHER; will replace Tanger Factory Outlet... More
Blueprint Medicines (BPMC) Announces Proposed $325M Public Offering of Shares of Common Stoc
January 21, 2020 4:18 PM ESTBlueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it has commenced an underwritten public offering of $325,000,000 in shares of its common stock. In addition, Blueprint Medicines expects to grant the underwriters a 30-day option to purchase up to an additional $48,750,000 in shares of its common stock in connection with the public offering. All shares of common stock will be offered by Blueprint... More
